Market appears sick of regulatory approvals - it wants revenue. If the product is good then it should sell but unitl it does the maket has announced, quite profoundly, that they are not going to back it, period. Its annoying because utter crap stocks like Afterpay never make a cent but they fly because the media prints stories about them every day. RHY has a great lifesaving product, but no one give a crap about it.
Market appears sick of regulatory approvals - it wants revenue....
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
